{"entity":{"type":"insider","cik":"0001585663","url":"/insider/0001585663","json_url":"/insider/0001585663.json","name":"Wennogle Lawrence P.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":11,"n_filings":8,"first":"2014-05-23","last":"2015-06-09","span_basis":"filed_date"},"name_variants":[{"name":"Wennogle Lawrence P.","source":"filing","n_filings":8,"first_seen":"2014-05-23","last_seen":"2015-06-09"}],"transactions":[{"id":8209380,"accession":"0001181431-15-008059","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-15-008059","line_url":"/filing/0001181431-15-008059#line-1","is_derivative":false,"issuer_cik":"0001567514","issuer_name":"Intra-Cellular Therapies, Inc.","issuer_ticker":"ITCI","issuer_name_source":null,"issuer_url":"/issuer/0001567514","owner_cik":"0001585663","owner_name":"Wennogle Lawrence P.","owner_display_name":"Wennogle Lawrence P.","owner_url":"/insider/0001585663","role":"Officer (Vice President, Drug Discovery)","role_mark":"O","role_mark_label":"Officer (Vice President, Drug Discovery)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Vice President, Drug Discovery","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25000.0,"shares_display":"25,000","price_per_share":26.84,"price_display":"26.84","price_state":"stated","total_value":671000.0,"total_display":"671,000.00","total_whole":"671,000","shares_owned_after":126500.0,"shares_owned_after_display":"126,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-06-08","filed_date":"2015-06-09","scope":"insider"},{"id":6834612,"accession":"0001181431-14-034466","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-14-034466","line_url":"/filing/0001181431-14-034466#line-1","is_derivative":false,"issuer_cik":"0001567514","issuer_name":"Intra-Cellular Therapies, Inc.","issuer_ticker":"ITCI","issuer_name_source":null,"issuer_url":"/issuer/0001567514","owner_cik":"0001585663","owner_name":"Wennogle Lawrence P.","owner_display_name":"Wennogle Lawrence P.","owner_url":"/insider/0001585663","role":"Officer (Vice President, Drug Discovery)","role_mark":"O","role_mark_label":"Officer (Vice President, Drug Discovery)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Vice President, Drug Discovery","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5152.0,"shares_display":"5,152","price_per_share":15.0,"price_display":"15.00","price_state":"stated","total_value":77280.0,"total_display":"77,280.00","total_whole":"77,280","shares_owned_after":104000.0,"shares_owned_after_display":"104,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-10-16","filed_date":"2014-10-17","scope":"insider"},{"id":6610617,"accession":"0001181431-14-034305","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-14-034305","line_url":"/filing/0001181431-14-034305#line-2","is_derivative":false,"issuer_cik":"0001567514","issuer_name":"Intra-Cellular Therapies, Inc.","issuer_ticker":"ITCI","issuer_name_source":null,"issuer_url":"/issuer/0001567514","owner_cik":"0001585663","owner_name":"Wennogle Lawrence P.","owner_display_name":"Wennogle Lawrence P.","owner_url":"/insider/0001585663","role":"Officer (Vice President, Drug Discovery)","role_mark":"O","role_mark_label":"Officer (Vice President, Drug Discovery)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Vice President, Drug Discovery","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2004.0,"shares_display":"2,004","price_per_share":15.0,"price_display":"15.00","price_state":"stated","total_value":30060.0,"total_display":"30,060.00","total_whole":"30,060","shares_owned_after":109152.0,"shares_owned_after_display":"109,152","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-10-15","filed_date":"2014-10-15","scope":"insider"},{"id":6610612,"accession":"0001181431-14-034305","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-14-034305","line_url":"/filing/0001181431-14-034305#line-1","is_derivative":false,"issuer_cik":"0001567514","issuer_name":"Intra-Cellular Therapies, Inc.","issuer_ticker":"ITCI","issuer_name_source":null,"issuer_url":"/issuer/0001567514","owner_cik":"0001585663","owner_name":"Wennogle Lawrence P.","owner_display_name":"Wennogle Lawrence P.","owner_url":"/insider/0001585663","role":"Officer (Vice President, Drug Discovery)","role_mark":"O","role_mark_label":"Officer (Vice President, Drug Discovery)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Vice President, Drug Discovery","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1600.0,"shares_display":"1,600","price_per_share":15.0,"price_display":"15.00","price_state":"stated","total_value":24000.0,"total_display":"24,000.00","total_whole":"24,000","shares_owned_after":111156.0,"shares_owned_after_display":"111,156","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-10-13","filed_date":"2014-10-15","scope":"insider"},{"id":6554035,"accession":"0001181431-14-034197","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-14-034197","line_url":"/filing/0001181431-14-034197#line-1","is_derivative":false,"issuer_cik":"0001567514","issuer_name":"Intra-Cellular Therapies, Inc.","issuer_ticker":"ITCI","issuer_name_source":null,"issuer_url":"/issuer/0001567514","owner_cik":"0001585663","owner_name":"Wennogle Lawrence P.","owner_display_name":"Wennogle Lawrence P.","owner_url":"/insider/0001585663","role":"Officer (Vice President, Drug Discovery)","role_mark":"O","role_mark_label":"Officer (Vice President, Drug Discovery)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Vice President, Drug Discovery","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4745.0,"shares_display":"4,745","price_per_share":15.0,"price_display":"15.00","price_state":"stated","total_value":71175.0,"total_display":"71,175.00","total_whole":"71,175","shares_owned_after":112756.0,"shares_owned_after_display":"112,756","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-10-08","filed_date":"2014-10-10","scope":"insider"},{"id":6554027,"accession":"0001181431-14-033874","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-14-033874","line_url":"/filing/0001181431-14-033874#line-2","is_derivative":false,"issuer_cik":"0001567514","issuer_name":"Intra-Cellular Therapies, Inc.","issuer_ticker":"ITCI","issuer_name_source":null,"issuer_url":"/issuer/0001567514","owner_cik":"0001585663","owner_name":"Wennogle Lawrence P.","owner_display_name":"Wennogle Lawrence P.","owner_url":"/insider/0001585663","role":"Officer (Vice President, Drug Discovery)","role_mark":"O","role_mark_label":"Officer (Vice President, Drug Discovery)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Vice President, Drug Discovery","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":636.0,"shares_display":"636","price_per_share":15.0,"price_display":"15.00","price_state":"stated","total_value":9540.0,"total_display":"9,540.00","total_whole":"9,540","shares_owned_after":117501.0,"shares_owned_after_display":"117,501","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-10-06","filed_date":"2014-10-07","scope":"insider"},{"id":6554026,"accession":"0001181431-14-033874","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-14-033874","line_url":"/filing/0001181431-14-033874#line-1","is_derivative":false,"issuer_cik":"0001567514","issuer_name":"Intra-Cellular Therapies, Inc.","issuer_ticker":"ITCI","issuer_name_source":null,"issuer_url":"/issuer/0001567514","owner_cik":"0001585663","owner_name":"Wennogle Lawrence P.","owner_display_name":"Wennogle Lawrence P.","owner_url":"/insider/0001585663","role":"Officer (Vice President, Drug Discovery)","role_mark":"O","role_mark_label":"Officer (Vice President, Drug Discovery)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Vice President, Drug Discovery","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15863.0,"shares_display":"15,863","price_per_share":15.0,"price_display":"15.00","price_state":"stated","total_value":237945.0,"total_display":"237,945.00","total_whole":"237,945","shares_owned_after":118137.0,"shares_owned_after_display":"118,137","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-10-03","filed_date":"2014-10-07","scope":"insider"},{"id":7031663,"accession":"0001181431-14-032227","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-14-032227","line_url":"/filing/0001181431-14-032227#line-1","is_derivative":false,"issuer_cik":"0001567514","issuer_name":"Intra-Cellular Therapies, Inc.","issuer_ticker":"ITCI","issuer_name_source":null,"issuer_url":"/issuer/0001567514","owner_cik":"0001585663","owner_name":"Wennogle Lawrence P.","owner_display_name":"Wennogle Lawrence P.","owner_url":"/insider/0001585663","role":"Officer (Vice President, Drug Discovery)","role_mark":"O","role_mark_label":"Officer (Vice President, Drug Discovery)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Vice President, Drug Discovery","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":15.0,"price_display":"15.00","price_state":"stated","total_value":75000.0,"total_display":"75,000.00","total_whole":"75,000","shares_owned_after":134000.0,"shares_owned_after_display":"134,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-09-15","filed_date":"2014-09-17","scope":"insider"},{"id":7064755,"accession":"0001181431-14-021707","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-14-021707","line_url":"/filing/0001181431-14-021707#line-1","is_derivative":false,"issuer_cik":"0001567514","issuer_name":"Intra-Cellular Therapies, Inc.","issuer_ticker":"ITCI","issuer_name_source":null,"issuer_url":"/issuer/0001567514","owner_cik":"0001585663","owner_name":"Wennogle Lawrence P.","owner_display_name":"Wennogle Lawrence P.","owner_url":"/insider/0001585663","role":"Officer (Vice President, Drug Discovery)","role_mark":"O","role_mark_label":"Officer (Vice President, Drug Discovery)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Vice President, Drug Discovery","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":15.0,"price_display":"15.00","price_state":"stated","total_value":75000.0,"total_display":"75,000.00","total_whole":"75,000","shares_owned_after":101500.0,"shares_owned_after_display":"101,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-05-27","filed_date":"2014-05-29","scope":"insider"},{"id":6609938,"accession":"0001181431-14-021200","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-14-021200","line_url":"/filing/0001181431-14-021200","is_derivative":false,"issuer_cik":"0001567514","issuer_name":"Intra-Cellular Therapies, Inc.","issuer_ticker":"ITCI","issuer_name_source":null,"issuer_url":"/issuer/0001567514","owner_cik":"0001585663","owner_name":"Wennogle Lawrence P.","owner_display_name":"Wennogle Lawrence P.","owner_url":"/insider/0001585663","role":"Officer (Vice President, Drug Discovery)","role_mark":"O","role_mark_label":"Officer (Vice President, Drug Discovery)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Vice President, Drug Discovery","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6000.0,"shares_display":"6,000","price_per_share":14.997176666666666,"price_display":"15.00","price_state":"stated","total_value":89983.06,"total_display":"89,983.06","total_whole":"89,983","shares_owned_after":106500.0,"shares_owned_after_display":"106,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-05-22","filed_date":"2014-05-23","scope":"insider","n_lines":2}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":11,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":11,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":11},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001567514","name":"Intra-Cellular Therapies, Inc.","url":"/issuer/0001567514","role":"Officer (Vice President, Drug Discovery)","n_filings":8,"first_seen":"2014-05-23","last_seen":"2015-06-09"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001585663","retrieved_at":"2026-08-26T13:33:38+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-25","last_ingest":"2026-08-26T05:24:25.741053+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}